Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Markers of Pulmonary Dysbiosis Associated With Exacerbation in Patients Followed for Cystic Fibrosis

NCT03569904 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT03569904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03569904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Markers of Pulmonary Dysbiosis Associated With Exacerbation in Patients Followed for Cystic Fibrosis
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Unknown status
Start date
October 2, 2018
Completion date
December 31, 2021
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis pulmonary exacerbation